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Adverse outcomes after arthroscopic partial meniscectomy: 
a study of 700 000 procedures in the national Hospital 
Episode Statistics database for England
Simon G F Abram, Andrew Judge, David J Beard, Andrew J Price
Summary
Background Arthroscopic partial meniscectomy is one of the most common orthopaedic procedures worldwide. 
Clinical trial evidence published in the past 6 years, however, has raised questions about the effectiveness of the 
procedure in some patient groups. In view of concerns about potential overuse, we aimed to establish the true risk of 
serious complications after arthroscopic partial meniscectomy.
Methods We analysed national Hospital Episode Statistics data for all arthroscopic partial meniscectomies done in 
England between April 1, 1997, and March 31, 2017. Simultaneous or staged (within 6 months) bilateral cases were 
excluded. We identified complications occurring in the 90 days after the index procedure. The primary outcome was 
the occurrence of at least one serious complication within 90 days, which was defined as either myocardial infarction, 
stroke, pulmonary embolism, infection requiring surgery, fasciotomy, neurovascular injury, or death. Logistic 
regression modelling was used to identify factors associated with complications and, when possible, risk was 
compared with general population data.
Findings During the study period 1 088 782 arthroscopic partial meniscectomies were done, 699 965 of which were 
eligible for analysis. Within 90 days, serious complications occurred in 2218 (0·317% [95% CI 0·304–0·330]) cases, 
including 546 pulmonary embolisms (0·078% [95% CI 0·072–0·085]) and 944 infections necessitating further 
surgery (0·135% [95% CI 0·126–0·144]). Increasing age (adjusted odds ratio [OR] 1·247 per decade [95% CI 
1·208–1·288) and modified Charlson comorbidity index (adjusted OR 1·860 per 10 units [95% CI 1·708–2·042]) were 
associated with an increased risk of serious complications. Female sex was associated with a reduced risk of serious 
complications (adjusted OR 0·640 [95% CI 0·580–0·705). The risk of mortality fell over time (adjusted OR 0·965 per 
year [95% CI 0·937–0·994]). Mortality, myocardial infarction, and stroke occurred less frequently in the study cohort 
than in the general population. The risks of infection and pulmonary embolism did not change during the study, and 
were significantly higher in the study cohort than in the general population. For every 1390 (95% CI 1272–1532) fewer 
knee arthroscopies done, one pulmonary embolism could be prevented. For every 749 (95% CI 704–801) fewer 
procedures done, one native knee joint infection could be prevented.
Interpretation Overall, the risk associated with undergoing arthroscopic partial meniscectomy was low. However, 
some rare but serious complications (including pulmonary embolism and infection) are associated with the 
procedure, and the risks have not fallen with time. In view of uncertainty about the effectiveness of arthroscopic 
partial meniscectomy, an appreciation of relative risks is crucial for patients and clinicians. Our data provide a basis 
for decision making and consent.
Funding UK National Institute for Health Research.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Meniscal tears are common but associated with highly 
variable knee symptoms, signs, and radiological findings.1,2 
Many meniscal tears are asymptomatic, and knee symp­
toms can often be attributed to other pathologies, such as 
osteoarthritis.1,3–5 When a meniscal tear is judged to be the 
cause of symptoms, surgical treatment to excise the 
unstable meniscal tissue—arthroscopic partial menisc­
ectomy—is frequently rec ommended, and is one of the 
most common orthopaedic surgical procedures world­
wide.6,7 However, after the publication of the results 
of several randomised con trolled clinical trials,8–13 the 
effectiveness of arthro scopic partial meniscectomy has 
been debated.14–19 In view of concerns that the procedure 
might be overused, a key concern is the occurrence of rare 
but serious complications.20
Estimates of the frequency of complications after arthro­
scopic knee surgery vary widely, and previous studies have 
had several limitations.20 In many studies, the cohorts 
comprised a mixture of patients who under went major 
procedures with combined open techniques, such as 
ligament reconstruction, and those who under went less 
invasive and purely arthroscopic procedures, such as 
arthroscopic partial meniscectomy (appendix).20 Studies 
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have also frequently been limited by small population or a 
reliance upon regional or insurance company databases, 
which could under­represent the true frequency of com­
plications. The focus of several studies was venous 
thromboembolic complications or infection only, and 
comparisons between studies are challenging because of 
variations in populations, age groups, health systems, 
insurance providers, data sources, data collection, coding, 
and methods. There has been increased scrutiny of the 
requirement for individual ised patient consent to undergo 
surgery or another invasive procedure.21 Estimation of an 
individual’s attributable risk from undergoing a procedure, 
rather than the unadjusted absolute risk, is crucial, and 
previous studies have been unable to calculate this 
important informa tion because of the absence of com­
parison to general population data.
We aimed to comprehensively analyse the risk of com­
plications associated with undergoing isolated arthro­
scopic partial meniscectomy based on the National Health 
Service (NHS) and Office for National Statistics (ONS) 
databases for England. When data were available, com­
parison was made to the risk of adverse events such as 
mortality, pulmonary embolism, myocardial infarction, 
and stroke in the general population, to guide patients 
and clinicians about the relative risk of undergoing the 
procedure.
Methods
Data sources
We did an analysis of prospectively collected, national, 
hospital care data in England. We obtained national 
Hospital Episode Statistics (HES) data from NHS Digital 
(application DARS­NIC­68703), which was linked with the 
ONS mortality dataset. HES contains a record of all patient 
attendances at NHS hospitals in England, and covers 
episodes of care delivered in treatment centres (including 
those in the independent sectors) funded by the NHS, 
episodes of care in England when patients are resident 
Research in context
Evidence before this study
A meta-analysis of studies of adverse events after knee 
arthroscopy, published in 2015, included summary estimates of 
deep vein thrombosis (0·413% [95% CI 0·178–0·960]; 
five studies of 432 663 patients or procedures), pulmonary 
embolism (0·145% [0·059–0·354]; six studies of 
736 823 patients or procedures), venous thromboembolism—
ie, deep vein thrombosis or pulmonary embolism—(0·568% 
[0·296–1·090]; six studies of 571 793 patients or procedures), 
infection (0·211% [0·080–0·556]; four studies of 
946 230 patients or procedures), and death (0·096% 
[0·004–2·390; two studies of 106 967 patients or procedures). 
Heterogeneity (I²) in all these estimates exceeded 90% and the 
included studies had several limitations. Studies had inconsistent 
inclusion criteria, often included patients undergoing complex 
arthroscopic procedures (such as ligament reconstruction), 
and had different outcomes, endpoints, and units of analysis 
(ie, patient or procedure). The completeness of case capture in 
insurance company databases was also of concern (where 
applicable). Thus, CIs were wide, the range of complications 
reported was incomplete, and the generalisability of the findings 
to patients undergoing the most common procedure, 
arthroscopic partial meniscectomy, in isolation was unknown. 
We did an updated search of MEDLINE, Embase, CENTRAL, 
and CINAHL on Feb 8, 2018, and followed the published search 
strategy from the previous meta-analysis of harms. We identified 
four subsequent studies of venous thromboembolism and one 
study of infection, in which the frequencies of these 
complications was similar to those in the previous meta-analysis. 
In a cohort study of 45 943 patients, myocardial infarction 
occurred in 23 (0·05%) within 30 days of knee arthroscopy. For 
comparison, in the general population, the previously reported 
90-day risk of mortality is 0·158%, of myocardial infarction is 
0·058% (in men younger than 80 years; the corresponding 
frequency in women is 0·028%), of pulmonary embolism is 
0·006%, of stroke is 0·034%, and of non-iatrogenic septic 
arthritis is 0·001%.
Added value of this study
We assessed a wide range of serious complications in a cohort 
restricted to patients undergoing arthroscopic partial 
meniscectomy only. To our knowledge, our study is the largest 
reported single database cohort so far of knee arthroscopy 
procedures (699 965 cases). Arthroscopic partial meniscectomy 
was associated with a 0·317% risk of serious complications 
within 90 days (pulmonary embolism, myocardial infarction, 
stroke, fasciotomy, neurovascular injury, infection requiring 
surgery, or death). Increasing age was associated with an 
increased risk of serious complications, and female patients 
were at decreased risk of serious complications. Compared with 
the general population, arthroscopic partial meniscectomy was 
associated with an increased risk of septic arthritis and 
pulmonary embolism, and neither risk has improved over time 
despite modern prophylactic methods. For every 1500 fewer 
knee arthroscopies done, one pulmonary embolism and 
two native knee joint infections could be prevented.
Implications of all the available evidence
Overall, our findings suggest that arthroscopic partial 
meniscectomy is a low-risk procedure, and should continue to 
be used in carefully selected patients. However, the increased 
risks of pulmonary embolism and septic arthritis, rare but 
serious complications, are important to consider because up to 
2 million knee arthroscopies are done worldwide each year. 
Our data will help to inform patient decision making and 
consent. Continued focus on the development of refined patient 
selection criteria is justified to avoid exposure to potentially 
avoidable risks.
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outside England, and privately funded patients treated 
within NHS England hospitals.22 The information recorded 
in the HES database includes patient demo graphic and 
residence data, primary and secondary diagnoses including 
comorbidities, and all procedures done. The ONS mortality 
dataset contains national death certificate data, irrespective 
of whether the death occurred in hospital or the com­
munity. For the purposes of this study, the date of death 
and cause of death (according to the 10th edition of the 
International Classification of Diseases and Related Health 
Problems [ICD­10]) were extracted and linked to the 
corresponding HES records for patients. Ethical approval 
was not required for this study.
Procedures
We extracted data for patients who underwent arthro scopic 
partial meniscectomy from HES records between 
April 1, 1997, and March 31, 2017. Episodes were identified 
from the Classification of Surgical Operations and 
Procedures (OPCS­4) codes in the procedure fields within 
the HES data (W82.2).23 Only isolated cases of arthroscopic 
partial meniscectomy were included; simultaneous or 
staged (within 6 months) bilateral cases were excluded. Per 
patient, per side, only the primary arthroscopic partial 
meniscectomy was included as an index procedure. Sub­
sequent revision procedures in the same patient were 
counted as reoperation complications if done within 
90 days of the index procedure in the same knee. For each 
patient identified as undergoing an index arthroscopic 
partial meniscectomy, all the patient’s previous and 
subsequent hospital episodes were identified for the entire 
data­extraction period, to identify adverse events and 
improve the completeness and accuracy of data extraction 
for each procedure and patient. Procedures for which 
essential data (ie, age or sex of patient, procedure date, 
procedure laterality) were missing were excluded from the 
study. Patients for whom non­essential data (ie, index of 
multiple deprivation, ethnicity, rurality) were missing were 
included in the study but excluded from analyses in which 
the missing variable was adjusted for.
Complications during the 90 days after the index 
procedure were identified by review of the 20 ICD­10 
diagnosis fields per hospital episode and 24 OPCS 
operation fields per episode.23,24 Complica tions identified 
from the ICD­10 diagnosis fields were pul monary embo­
lism, myocardial infarction, stroke, lower­res piratory­
tract infection, acute kidney injury, urinary tract infection, 
and neurovascular injury. Com plications identi fied 
from the OPCS operation codes were con firmed to match 
the laterality (left vs right) of the index procedure with 
the OPCS laterality codes. The procedure­based compli­
cations were joint infection, fasciotomy, and reoperation. 
Mortality data were extracted from the linked ONS 
mortality fields.
Outcomes
The primary outcome was the occurrence of at least 
one serious complication within 90 days of an index 
arthroscopic partial meniscectomy. A serious com pli­
cation was defined as either myocardial infarc tion, stroke, 
pulmonary embolism, infection requiring sur gery, 
fasciotomy, neurovascular injury, or death. The frequency 
of each individual complication was then assessed 
secondarily, with each complication counted whether in 
isolation or in combination with other adverse outcomes.
Statistical analysis
Descriptive statistics were used to report demog raphic 
data. Complication rates were reported with 95% CIs 
corresponding to the proportion of the study sample. In 
accordance with ONS and NHS Digital guid ance, if fewer 
than six events were recorded, data were suppressed.25
We used logistic regression methods to first calculate 
the unadjusted odds of each complication by age group, 
sex, index of multiple deprivation (quintiles derived from 
regional factors in England including average income, 
employment, education, housing, and crime; quintile 1 
includes the least deprived areas, quintile 5 includes the 
most deprived), ethnicity, modified Charlson co­morbidity 
index (Summary Hospital­level Mortality Indicator 
Specification; derived with maximum 5­year diagnosis 
code look­back period), year of treatment, ethnicity, and 
rurality.26–29 The odds ratios (ORs) were then adjusted by 
including all these variables in the same model.
To guide patients and clinicians about the relative risk 
of undergoing arthroscopic partial meniscectomy, 
gen eral population data were reviewed. Population and 
adverse event numbers were extracted from the ONS 
nation al mortality report, and from publications in which 
Figure 1: Case selection
*938 612 patients. †Same side or contralateral surgical procedures (not mutually 
exclusive). ‡Includes primary or revision total knee arthroplasty, unspecified 
meniscal surgery, total meniscectomy, meniscal transplant, fusion, interposition, 
washout, synovial or fat pad procedures. §702 401 patients. ¶666 442 patients.
1 088 782 cases of arthroscopic partial meniscectomies listed in Hospital 
 Episode Statistics database*
300 578 cases excluded because of concurrent procedures†
 152 858 chondroplasty
 34 053 ligamentous surgery
 5012 meniscal repair
 131 952 other‡
788 204 cases§
88 239 cases excluded for other reasons
 17 222 simultaneous bilateral
 9615 staged bilateral (<6 months)
 36 882 non-primary arthroscopic partial meniscectomy 
  procedures
 24 520 data missing or erroneous
699 965 cases included in study cohort¶
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population­level rates of myocardial infarction, pulmonary 
embolus, stroke, or septic arthritis were reported.30–34 
Annualised rates were adjusted directly to estimate 90­day 
complication rates. The relative risk of each adverse event 
after arthroscopic partial meniscectomy was calculated by 
comparing the adverse event rates in an age­matched and 
sex­matched sample of our study population to that 
calculated in the general population. The number needed 
to harm was calculated as the reciprocal of the risk 
difference between the study cohort and the general 
population (attributable risk). We used Stata (version 15.1) 
for all analyses.
Role of the funding source
The study sponsors had no role in study design; data 
collection, analysis, or interpretation; or writing of the 
report. All authors had access to all study data and had 
final responsibility for the decision to submit for 
publication.
Results
Between April 1, 1997, and March 31, 2017, 1 088 782 arth­
ro scopic partial meniscectomies were done. 699 965 isol­
ated procedures in 666 442 patients were eligible for 
inclusion as index procedures (figure 1). In table 1 we 
summarise the characteristics of the overall cohort 
and patients developing serious complications within 
90 days. Arthroscopic partial meniscectomies were done 
more frequently in men (453 726 [64·82%] cases) than 
women (246 239 [35·18%] cases) and most commonly in 
people aged 40–59 years (330 752 [47·25%] cases; table 1).
4239 cases of reoperation (planned or unplanned) were 
recorded (0·606% [95% CI 0·588–0·624]; table 2). Of 
these reoperations, 944 (0·135% [0·126–0·144]) were done 
because of infection (table 2). Serious complications 
occurred in 2218 cases (0·317% [0·304–0·330]), and 
217 deaths were recorded within 90 days of the index 
procedure (0·031% [0·027–0·035]). Pulmonary embolism 
occurred in 546 cases (0·078% [0·072–0·085]), ten of 
which were fatal (0·001% [0·000–0·003]; table 2).
Female sex was associated with a decreased risk of 
complications compared with male sex (OR 0·640 [95% CI 
0·580–0·705]; figure 2), partly driven by an increased risk 
of myocardial infarction and infection in male patients 
(table 3). Increasing age was associated with an increased 
risk of serious complications (adjusted OR 1·247 per 
decade [95% CI 1·208–1·288]). Serious complications 
occurred in 76 (1·01%) cases in patients aged 80 years or 
older and 32 (0·15%) of cases in patients younger than 
20 years, a difference that corresponded to an adjusted OR 
of 5·794 (95% CI 3·740–8·975). Increased comorbidity 
was associated with an increased risk of myocardial 
infarction, stroke, infection, death, and the overall risk of 
serious complications (table 3). Complications occurred 
more frequently in areas of increased deprivation (figure 2; 
table 3). Rurality and ethnicity did not affect the risk of 
serious complications (figure 2; table 3). The rate of 
serious complications fell slightly during the 20­year study 
period (adjusted OR 0·987 per year [95% CI 0·978–0·996]; 
table 3).
The risk of 90­day mortality was lower in the study 
population undergoing arthroscopic partial meniscec­
tomy than the national rate of mortality (excluding deaths 
from cancer) in patients aged 40 years or older (table 4). 
The risk of myocardial infarction and stroke in our cohort 
was similar to or lower than that in the general population 
(table 4). The relative risk of pulmonary embolism (risk 
ratio 12·99 [95% CI 10·35–16·31]) and septic arthritis 
(110·21 [81·19–149·60]) were higher in our study 
population than in the general population. For pulmonary 
embolism, the estimated number needed to harm was 
1390 (95% CI 1272–1532). For native knee joint infection, 
the estimated number needed to harm was 749 (95% CI 
All procedures Serious complications*
Overall 699 965 (100%) 2218 (0·32%, 0·30–0·33)
Sex
Male 453 726 (64·82%) 1545 (0·34%, 0·32–0·36)
Female 246 239 (35·18%) 673 (0·27%, 0·25–0·29)
Age group, years
<20 21 798 (3·11%) 32 (0·15%, 0·10–0·21)
20–39 172 636 (24·66%) 356 (0·21%, 0·19–0·23)
40–59 330 752 (47·25%) 988 (0·30%, 0·28–0·32)
60–79 167 287 (23·90%) 766 (0·46%, 0·43–0·49)
≥80 7492 (1·07%) 76 (1·01%, 0·80–1·27)
Modified Charlson comorbidity index
0 590 110 (84·31%) 1660 (0·28%, 0·26–0·30)
1–15 105 689 (15·10%) 497 (0·47%, 0·43–0·51)
16–30 3881 (0·55%) 52 (1·34%, 1·00–1·75)
31–50 285 (0·04%) 9 (3·16%, 1·45–5·91)
Index of multiple deprivation
Quintile 1 168 715 (24·10%) 489 (0·29%, 0·26–0·32)
Quintile 2 156 657 (22·38%) 493 (0·31%, 0·29–0·34)
Quintile 3 145 000 (20·72%) 497 (0·34%, 0·31–0·37)
Quintile 4 123 913 (17·70%) 403 (0·33%, 0·29–0·36)
Quintile 5 100 320 (14·33%) 326 (0·32%, 0·29–0·36)
Missing 5360 (0·77%) ··
Rurality
Urban 547 459 (78·21%) 1712 (0·31%, 0·30–0·33)
Rural 149 882 (21·41%) 504 (0·34%, 0·31–0·37)
Missing 2624 (0·37%) ··
Ethnic origin
White 564 320 (80·62%) 1911 (0·34%, 0·32–0·35)
Asian 18 555 (2·65%) 51 (0·27%, 0·20–0·36)
Black 11 222 (1·60%) 41 (0·37%, 0·26–0·50)
Mixed race 3870 (0·55%) 13 (0·34%, 0·18–0·57)
Other 6547 (0·94%) 14 (0·21%, 0·12–0·36)
Missing 95 451 (13·64%) ··
Data are n (%) or n (%, 95% CI). *At least one serious complication within 90 days, 
defined as either pulmonary embolism, myocardial infarction, stroke, infection 
requiring surgery, fasciotomy, neurovascular injury, or death.
Table 1: Demographics and descriptive statistics
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704–801). We noted ten (1·8%) fatal pulmonary 
embolisms among the 546 cases rec orded, and estimated 
one attributable death from pulmon ary embolism for 
every 77 519 arthroscopic partial meniscectomies (95% CI 
45 455–261 097).
Discussion
Our study of 699 965 cases of arthroscopic partial 
meniscectomy shows that complications occur rarely after 
the procedure. Although the risk of some complications 
increased with increasing age, in patients with com­
orbidities, and in men, most adverse events were less 
common in our study population than in the general 
population (table 4). We noted a small but significant 
decrease in the risk of mortality after arthroscopic partial 
meniscectomy during the 20­year study period, which has 
been previously reported for total joint arthroplasty 
surgery.35,36 The risk of infection and pulmonary embolism, 
however, was substantially in creased after arthroscopic 
partial meniscectomy, with a number needed to harm of 
1390 for pulmonary embolism and 749 for native knee 
joint infection. One death from pulmonary embolism 
could be prevented if 77 519 fewer arthroscopic partial 
meniscectomies were done.
Reports of several clinical trials of arthroscopic partial 
meniscectomy have now been published and their findings 
suggest that, for many patient groups, exercise therapy 
could be an effective treatment.8–13 In the trials published 
so far, patients had so­called degenerative meniscal tears 
and mean age has ranged from 47 to 58.8–13 The trial 
evidence applicable to this population can now be 
interpreted in the context of risk, and our study provides 
an indication of the potential morbidity associated with 
overuse of knee arthroscopy.
The absolute rate of pulmonary embolism, infection, 
and death in our study was less than the pooled estimate 
reported by a meta­analysis20 of previous studies 
(appendix). This finding is likely to be related to reduced 
heterogeneity in our analysis, which was limited to 
patients undergoing isolated arthroscopic partial men­
iscectomy and excluded complex procedures such as 
anterior cruciate ligament reconstruction. Nevertheless, 
we estimated a 13­times greater risk of developing a 
pulmonary embolism after the procedure compared with 
the risk in the general population (table 4), which probably 
reflects the fact that only around 25% of pulmon­
ary embolisms occur in unprovoked circumstances 
(ie, without a history of surgery, cancer, hospitalisation, 
pregnancy, or trauma).32,37 The risk of pulmonary 
embolism did not change in our cohort over time (table 3), 
despite modern attention to prevention of venous 
thrombo embolism.38 The rate of fatal pulmonary embol­
ism in our series was similar to that in other 
series.39 Although rare, the increased risk of pulmonary 
embolism is concerning because thromboprophylaxis 
is not advocated routinely for people undergoing 
knee arthro scopy.40 As shown in studies35,36 of patients 
under going joint arthroplasty, venous thromboembolism 
can be prevent ed with mech anical and chemical 
prophylaxis, but any potential benefits must be weighed 
n (% [95% CI])
Any reoperation* 4239 (0·606% [0·588–0·624])
Serious complication† 2218 (0·317% [0·304–0·330])
Infection‡ 944 (0·135% [0·126–0·144])
Lower-respiratory-tract infection 931 (0·133% [0·125–0·142])
Urinary tract infection 647 (0·092% [0·085–0·100])
Pulmonary embolism 546 (0·078% [0·072–0·085])
Myocardial infarction 279 (0·040% [0·035–0·045])
Mortality 217 (0·031% [0·027–0·035])
Stroke 208 (0·030% [0·026–0·034])
Acute kidney injury 206 (0·029% [0·026–0·034])
Neurovascular injury 67 (0·010% [0·007–0·012])
Fasciotomy 33 (0·005% [0·003–0·007])
Fatal pulmonary embolism 10 (0·001% [0·000–0·003])
N=699 965. *Any procedure done in the same knee (eg, washout, meniscal repair, 
repeat meniscectomy, chondroplasty, ligamentous surgery, fasciotomy).†At least 
one serious complication within 90 days, defined as either pulmonary embolism, 
myocardial infarction, stroke, infection requiring surgery, fasciotomy, neurovascular 
injury, or death. ‡Infection requiring surgery (open or arthroscopic washout).
Table 2: Complications within 90 days
Figure 2: Forest plot of adjusted odds of any serious complication within 90 days
Procedure-level multivariable logistic regression model adjusted for sex, age group, year, modified Charlson 
comorbidity index, index of multiple deprivation, rurality, and ethnicity. Error bars show 95% CIs. OR=odds ratio.
OR (95% CI)
Sex
 Male
 Female
Age group
 <20
 20–39
 40–59
 60–79
 ≥80
Year (per 1 year)
Modified Charlson comorbidity index 
(per 10 units)
Index of multiple deprivation
 Quintile 1
 Quintile 2
 Quintile 3
 Quintile 4
 Quintile 5
Rurality
 Urban
 Rural
Ethnicity
 White
 Asian
 Black
 Mixed race
 Other
1·000 (1·000–1·000)
0·640 (0·580–0·705)
0·500 (0·345–0·724)
0·679 (0·597–0·773)
1·000 (1·000–1·000)
1·417 (1·280–1·570)
2·898 (2·262–3·713)
0·987 (0·978–0·996)
1·860 (1·708–2·042)
1·000 (1·000–1·000)
1·062 (0·931–1·211)
1·178 (1·033–1·344)
1·204 (1·048–1·383)
1·194 (1·027–1·388)
1·000 (1·000–1·000)
1·075 (0·964–1·199)
1·000 (1·000–1·000)
0·855 (0·646–1·132)
1·224 (0·894–1·674)
1·200 (0·694–2·075)
0·725 (0·428–1·228)
10 3 42
Articles
www.thelancet.com   Vol 392   November 17, 2018 2199
Se
rio
us
 co
m
pl
ic
at
io
n*
Pu
lm
on
ar
y 
em
bo
lis
m
M
yo
ca
rd
ia
l i
nf
ar
ct
io
n
St
ro
ke
In
fe
ct
io
n†
De
at
h
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Cr
ud
e O
R 
(9
5%
 C
I)
Ad
ju
st
ed
 O
R 
(9
5%
 C
I)
Se
x
M
al
e
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
Fe
m
al
e
0·
80
2 
(0
·7
33
–0
·8
78
)
0·
64
0 
(0
·5
80
–0
·7
05
)
1·
31
1 
(1
·1
06
–1
·5
55
)
1·
02
1 
(0
·8
48
–1
·2
28
)
0·
57
1 
(0
·4
33
–0
·7
52
)
0·
40
6 
(0
·3
03
–0
·5
43
)
1·
32
5 
(1
·0
06
–1
·7
45
)
0·
81
8 
(0
·6
11
–1
·0
96
)
0·
49
2 
(0
·4
21
–0
·5
75
)
0·
45
4 
(0
·3
85
–0
·5
36
)
1·
21
0 
(0
·9
22
–1
·5
88
)
0·
85
2 
(0
·6
35
–1
·1
43
)
Ag
e 
gr
ou
p,
 y
ea
rs
<2
0
0·
49
1 
(0
·3
45
–0
·6
98
)
0·
50
0 
(0
·3
45
–0
·7
24
)
··
··
··
··
··
··
0·
99
3 
(0
·6
77
–1
·4
55
)
0·
92
5 
(0
·6
17
–1
·3
87
)
0·
21
4 
(0
·0
30
–1
·5
38
)
0·
26
1 
(0
·0
36
–1
·8
83
)
20
–3
9
0·
69
0 
(0
·6
11
–0
·7
79
)
0·
67
9 
(0
·5
97
–0
·7
73
)
0·
48
2 
(0
·3
69
–0
·6
31
)
0·
48
1 
(0
·3
58
–0
·6
46
)
0·
02
9 
(0
·0
07
–0
·1
16
)
0·
01
5 
(0
·0
02
–0
·1
09
)
0·
13
3 
(0
·0
54
–0
·3
29
)
0·
15
7 
(0
·0
63
–0
·3
92
)
1·
11
9 
(0
·9
57
–1
·3
08
)
1·
05
1 
(0
·8
91
–1
·2
39
)
0·
43
2 
(0
·2
51
–0
·7
43
)
0·
47
6 
(0
·2
69
–0
·8
41
)
40
–5
9
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
60
–7
9
1·
53
5 
(1
·3
97
–1
·6
88
)
1·
41
7 
(1
·2
80
–1
·5
70
)
1·
52
4 
(1
·2
70
–1
·8
29
)
1·
42
2 
(1
·1
66
–1
·7
34
)
1·
93
3 
(1
·5
18
–2
·4
62
)
1·
79
4 
(1
·3
77
–2
·3
38
)
3·
07
7 
(2
·2
88
–4
·1
37
)
2·
42
5 
(1
·7
61
–3
·3
40
)
1·
05
3 
(0
·8
97
–1
·2
37
)
1·
08
1 
(0
·9
11
–1
·2
82
)
2·
84
2 
(2
·0
99
–3
·8
47
)
2·
53
3 
(1
·8
14
–3
·5
36
)
≥8
0
3·
42
0 
(2
·7
06
–4
·3
24
)
2·
89
8 
(2
·2
62
–3
·7
13
)
1·
32
8 
(0
·6
57
–2
·6
84
)
1·
12
2 
(0
·5
25
–2
·3
99
)
4·
65
4 
(2
·6
82
–8
·0
76
)
4·
06
5 
(2
·2
77
–7
·2
57
)
11
·6
77
 
(7
·0
40
–1
9·
36
9)
6·
94
1 
(4
·0
17
–1
1·
99
3)
1·
03
2 
(0
·5
51
–1
·9
32
)
1·
11
9 
(0
·5
93
–2
·1
12
)
16
·8
46
 
(1
0·
80
9–
26
·2
54
)
11
·6
20
 
(7
·0
44
–1
9·
16
9)
Ye
ar
 o
f t
re
at
m
en
t (
pe
r y
ea
r)
Ye
ar
1·
00
0 
(0
·9
92
–1
·0
08
)
0·
98
7 
(0
·9
78
–0
·9
96
)
1·
01
0 
(0
·9
94
–1
·0
27
)
0·
99
7 
(0
·9
79
–1
·0
16
)
1·
01
2 
(0
·9
89
–1
·0
35
)
0·
98
3 
(0
·9
58
–1
·0
09
)
1·
02
5 
(0
·9
98
–1
·0
53
)
0·
99
2 
(0
·9
62
–1
·0
23
)
0·
99
2 
(0
·9
80
–1
·0
04
)
0·
98
9 
(0
·9
76
–1
·0
02
)
0·
99
0 
(0
·9
65
–1
·0
16
)
0·
96
5 
(0
·9
37
–0
·9
94
)
M
od
ifi
ed
 C
ha
rls
on
 co
m
or
bi
di
ty
 in
de
x 
(p
er
 u
ni
t)
Ch
ar
lso
n 
in
de
x
1·
08
3 
(1
·0
74
–1
·0
91
)
1·
06
4 
(1
·0
55
–1
·0
74
)
1·
04
8 
(1
·0
26
–1
·0
71
)
1·
02
3 
(0
·9
98
–1
·0
48
)
1·
11
3 
(1
·0
95
–1
·1
31
)
1·
08
1 
(1
·0
61
–1
·1
02
)
1·
14
4 
(1
·1
29
–1
·1
60
)
1·
11
0 
(1
·0
92
–1
·1
28
)
1·
02
7 
(1
·0
07
–1
·0
47
)
1·
03
0 
(1
·0
09
–1
·0
50
)
1·
13
3 
(1
·1
16
–1
·1
50
)
1·
09
9 
(1
·0
79
–1
·1
19
)
In
de
x 
of
 m
ul
ti
pl
e 
de
pr
iv
at
io
n 
(q
ui
nt
ile
)
1
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
2
1·
08
6 
(0
·9
58
–1
·2
31
)
1·
06
2 
(0
·9
31
–1
·2
11
)
1·
01
6 
(0
·7
88
–1
·3
09
)
0·
92
4 
(0
·7
02
–1
·2
18
)
1·
23
9 
(0
·8
76
–1
·7
51
)
1·
22
4 
(0
·8
50
–1
·7
61
)
1·
18
0 
(0
·7
76
–1
·7
92
)
1·
15
5 
(0
·7
48
–1
·7
83
)
1·
10
8 
(0
·9
16
–1
·3
41
)
1·
10
6 
(0
·9
08
–1
·3
46
)
1·
05
1 
(0
·6
80
–1
·6
24
)
1·
13
1 
(0
·7
18
–1
·7
81
)
3
1·
18
3 
(1
·0
44
–1
·3
41
)
1·
17
8 
(1
·0
33
–1
·3
44
)
1·
21
1 
(0
·9
45
–1
·5
51
)
1·
24
9 
(0
·9
61
–1
·6
24
)
1·
14
4 
(0
·7
99
–1
·6
39
)
1·
13
4 
(0
·7
74
–1
·6
61
)
1·
41
3 
(0
·9
39
–2
·1
26
)
1·
46
0 
(0
·9
58
–2
·2
24
)
1·
15
3 
(0
·9
51
–1
·3
97
)
1·
13
2 
(0
·9
28
–1
·3
82
)
1·
36
2 
(0
·8
98
–2
·0
67
)
1·
33
0 
(0
·8
49
–2
·0
82
)
4
1·
12
3 
(0
·9
84
–1
·2
81
)
1·
20
4 
(1
·0
48
–1
·3
83
)
1·
05
2 
(0
·8
05
–1
·3
75
)
1·
24
3 
(0
·9
39
–1
·6
46
)
0·
97
6 
(0
·6
60
–1
·4
44
)
1·
07
7 
(0
·7
09
–1
·6
36
)
1·
23
2 
(0
·7
94
–1
·9
11
)
1·
37
8 
(0
·8
73
–2
·1
77
)
1·
14
0 
(0
·9
33
–1
·3
94
)
1·
13
1 
(0
·9
17
–1
·3
96
)
1·
72
7 
(1
·1
47
–2
·6
01
)
2·
03
0 
(1
·3
10
–3
·1
45
)
5
1·
12
2 
(0
·9
75
–1
·2
91
)
1·
19
4 
(1
·0
27
–1
·3
88
)
1·
10
8 
(0
·8
37
–1
·4
66
)
1·
28
9 
(0
·9
52
–1
·7
44
)
1·
31
8 
(0
·8
99
–1
·9
30
)
1·
68
4 
(1
·1
23
–2
·5
26
)
1·
24
1 
(0
·7
80
–1
·9
75
)
1·
32
3 
(0
·8
00
–2
·1
86
)
1·
06
3 
(0
·8
54
–1
·3
21
)
1·
00
9 
(0
·8
00
–1
·2
73
)
1·
47
7 
(0
·9
44
–2
·3
11
)
1·
80
6 
(1
·1
07
–2
·9
44
)
Ru
ra
lit
y
Ur
ba
n
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
Ru
ra
l
1·
07
6 
(0
·9
74
–1
·1
88
)
1·
07
5 
(0
·9
64
–1
·1
99
)
1·
12
1 
(0
·9
20
–1
·3
67
)
1·
05
9 
(0
·8
49
–1
·3
23
)
1·
24
7 
(0
·9
52
–1
·6
33
)
1·
14
4 
(0
·8
46
–1
·5
48
)
1·
21
8 
(0
·8
90
–1
·6
67
)
1·
10
3 
(0
·7
80
–1
·5
58
)
1·
00
8 
(0
·8
63
–1
·1
77
)
1·
05
8 
(0
·8
95
–1
·2
50
)
1·
09
4 
(0
·7
97
–1
·5
00
)
1·
28
5 
(0
·9
08
–1
·8
16
)
Et
hn
ic
it
y
W
hi
te
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
1·
00
As
ia
n
0·
81
1 
(0
·6
14
–1
·0
72
)
0·
85
5 
(0
·6
46
–1
·1
32
)
0·
38
8 
(0
·1
73
–0
·8
68
)
0·
40
7 
(0
·1
82
–0
·9
14
)
1·
27
3 
(0
·6
76
–2
·3
96
)
1·
49
0 
(0
·7
86
–2
·8
24
)
0·
83
5 
(0
·3
44
–2
·0
32
)
0·
96
4 
(0
·3
94
–2
·3
60
)
0·
92
4 
(0
·6
20
–1
·3
76
)
0·
92
9 
(0
·6
22
–1
·3
88
)
0·
84
0 
(0
·3
45
–2
·0
43
)
0·
96
7 
(0
·3
95
–2
·3
69
)
Bl
ac
k
1·
07
9 
(0
·7
92
–1
·4
71
)
1·
22
4 
(0
·8
94
–1
·6
74
)
0·
64
2 
(0
·2
87
–1
·4
36
)
0·
67
6 
(0
·3
00
–1
·5
20
)
0·
21
0 
(0
·0
30
–1
·4
99
)
0·
27
8 
(0
·0
39
–1
·9
90
)
1·
10
5 
(0
·4
10
–2
·9
77
)
1·
48
1 
(0
·5
41
–4
·0
55
)
1·
59
0 
(1
·0
76
–2
·3
50
)
1·
72
5 
(1
·1
60
–2
·5
65
)
1·
11
1 
(0
·4
13
–2
·9
94
)
1·
37
5 
(0
·5
04
–3
·7
51
)
M
ix
ed
 ra
ce
0·
99
2 
(0
·5
74
–1
·7
13
)
1·
20
0 
(0
·6
94
–2
·0
75
)
0·
62
0 
(0
·1
55
–2
·4
88
)
0·
76
7 
(0
·1
91
–3
·0
83
)
0·
61
0 
(0
·0
86
–4
·3
49
)
1·
03
1 
(0
·1
44
–7
·3
74
)
0·
80
1 
(0
·1
12
–5
·7
20
)
1·
38
6 
(0
·1
93
–9
·9
31
)
1·
59
6 
(0
·8
27
–3
·0
81
)
1·
63
8 
(0
·8
46
–3
·1
71
)
··
··
O
th
er
0·
63
1 
(0
·3
73
– 1
·0
68
)
0·
72
5 
(0
·4
28
–1
·2
28
)
0·
55
0 
(0
·1
77
–1
·7
12
)
0·
63
3 
(0
·2
03
–1
·9
75
)
0·
36
1 
(0
·0
51
–2
·5
70
)
0·
53
1 
(0
·0
74
–3
·7
92
)
0·
47
4 
(0
·0
66
–3
·3
80
)
0·
76
1 
(0
·1
06
–5
·4
49
)
0·
41
9 
(0
·1
57
–1
·1
18
)
0·
41
9 
(0
·1
57
–1
·1
21
)
1·
90
5 
(0
·7
07
–5
·1
33
)
2·
75
6 
(1
·0
17
–7
·4
71
)
Pr
oc
ed
ur
e-
le
ve
l m
ul
tiv
ar
ia
bl
e 
lo
gi
st
ic 
re
gr
es
sio
n 
m
od
el
 a
dj
us
te
d 
fo
r s
ex
, a
ge
 g
ro
up
, y
ea
r, 
m
od
ifi
ed
 C
ha
rls
on
 co
m
or
bi
di
ty
 in
de
x,
 in
de
x o
f m
ul
tip
le
 d
ep
riv
at
io
n,
 ru
ra
lit
y,
 a
nd
 e
th
ni
cit
y. 
O
R=
od
ds
 ra
tio
. *
At
 le
as
t o
ne
 se
rio
us
 co
m
pl
ica
tio
n 
w
ith
in
 9
0 
da
ys
, 
de
fin
ed
 a
s e
ith
er
 p
ul
m
on
ar
y 
em
bo
lis
m
, m
yo
ca
rd
ia
l i
nf
ar
ct
io
n,
 st
ro
ke
, i
nf
ec
tio
n 
re
qu
iri
ng
 su
rg
er
y,
 fa
sc
io
to
m
y,
 n
eu
ro
va
sc
ul
ar
 in
ju
ry
, o
r d
ea
th
. †
In
fe
ct
io
n 
re
qu
iri
ng
 su
rg
er
y 
(o
pe
n 
or
 a
rt
hr
os
co
pi
c w
as
ho
ut
).
Ta
bl
e 3
: U
na
dj
us
te
d 
an
d 
ad
ju
st
ed
 o
dd
s o
f s
er
io
us
 co
m
pl
ic
at
io
ns
Articles
2200 www.thelancet.com   Vol 392   November 17, 2018
against the increased risk of bleeding. Our findings 
could inform a further re view of thrombo prophylaxis rec­
ommendations for patients undergoing arthroscopic 
partial meniscectomy, especially those in high­risk groups.
The overall risk of undergoing further surgery for 
infection within 90 days was also increased compared 
with the general population (table 4). Male patients 
and patients with comorbidities had an increased risk 
of undergoing surgery for infection (table 3). Whether 
antibiotic prophylaxis should be routinely given before 
knee arthroscopy is debated.41,42 The results of a study43 
published in 1988 suggested that prophylactic antibiotics 
might be cost effective if the infection rate associated 
with knee arthroscopy were greater than 0·08%. The rate 
of reoperation because of infection was higher than 
this threshold in our cohort. However, whether patients 
received antibiotic prophylaxis at the time of their index 
procedure was unknown. A contemporary cost­effective­
ness analysis is warranted to support any recommen­
dations about routine prophylaxis.
For low­risk procedures, the rate of complications 
compared with that in the general population is im portant 
to consider. This comparison is important to inform 
patients and clinicians of the relative risk of undergoing 
arthroscopic partial meniscectomy.21 For example, the risk 
of myocardial infarction in our cohort was similar in 
women to, and lower in men than, that reported in the 
general population, in whom the 90­day incidence in 
people younger than 80 years is around 0·058% in men 
and 0·028% in women.31 Similarly, stroke risk in our 
cohort was slightly lower than that in the general 
population younger than 75 years.33 Arthroscopic partial 
meniscectomy was most commonly done in patients 
aged 40–59 years, and 90­day mortality in this age group 
was 0·021%, compared with 0·043% in the general 
population (excluding deaths from cancer).30 Although 
this com parison is crude, the difference is similar to the 
39–43% relative mortality reported in patients undergoing 
total knee or total hip arthroplasty compared with the 
general population.44 The specific cause of the decreased 
mortality in our cohort relative to the general population is 
unknown, but is probably a so­called healthy patient 
selection bias, which is affected by differences in 
health­care seeking behaviour and access to surgical treat­
ment.45 The causes of the decreased mortality are likely 
to be many, and in the UK, for example, decreased 
mortality has been reported in indi viduals with spec­
ific occupations.46 Patients’ willingness to seek medical 
attention could be affected by the relative severity of a 
coexisting condition or by socioeconomic status. Equally, 
surgeons or anaesthetists might recom mend surgery 
less readily in patients whom they judge to be high risk 
because of the presence of comorbid disorders. In a study44 
of patients who underwent hip or knee arthroplasty, a 
reduced frequency of death from cancer was a key driver 
for reduced mortality in these patients relative to the 
general population.30 In our cohort, mortality was 
decreased even after deaths from cancer were excluded 
from the national population data. Increased mortality 
in the general population could still have been driven, 
for example, by over­representation of patients with 
severe cardiac or respiratory comorbidities. The risk of 
pulmonary embolism and infection only were greater in 
our cohort than in the general population. However, no 
comparison group was available for rarer direct surgical 
complications (eg, neurovascular injury, fasciotomy).
One of the main criticisms of previous studies of the 
risks of knee arthroscopy has been the analysis of cohorts 
comprising both patients undergoing simple, isolated, 
procedures such as arthroscopic partial meniscectomy 
and those undergoing complex and multiple procedures. 
No previous study has focused solely on arthrosco pic 
partial meniscectomy. To reduce heterogeneity, we care­
fully limited our analysis to isolated cases, and excluded 
patients undergoing bilateral surgery or any concurrent 
procedures. Application of these strict criteria meant that 
only 699 965 (64%) of 1 088 782 procedures in the HES 
database were included, yet our study remains the largest 
arthroscopic partial meniscectomy cohort reported so far. 
Our large sample of prospect ively recorded data enabled 
us to carefully control against potential confounding 
factors and increased the pre cision of our findings. 
Patient factors (especi ally age group, sex, and comor­
bidities) are probably more important than the health­
care delivery setting in estimation of the risk of adverse 
events, and thus our findings are likely to be broadly gen­
eralisable to other health­care settings and countries. 
Potential sources of unmeasured confounding, however, 
include body­mass index, smoking status, and issues of 
data qual ity, such as incomplete coding of comorbidity, 
in dica tion, or procedure. Furthermore our findings can­
not be generalised to patients undergoing more complex 
arthroscopic surgery.
General population risk % 
(95% CI)
Study cohort risk % 
(95% CI)
Risk ratio 
(95% CI)
Mortality30*
Overall 0·158% (0·157–0·159) 0·031% (0·027–0·035) 0·20 (0·17–0·22)
<20 years 0·007% (0·007–0·008) ·· ··
20–39 years 0·011% (0·011–0·012) 0·009% (0·005–0·015) 0·81 (0·49–1·32)
40–59 years 0·043% (0·042–0·044) 0·021% (0·017–0·027) 0·50 (0·40–0·63)
60–79 years 0·233% (0·230–0·236) 0·061% (0·050–0·074) 0·26 (0·22–0·32)
≥80 years 2·043% (2·026–2·060) 0·360% (0·238–0·524) 0·18 (0·12–0·26)
Myocardial infarction31
Men (<80 years) 0·058% (0·049–0·067) 0·046% (0·040–0·052) 0·79 (0·64–0·97)
Women (<80 years) 0·028% (0·022–0·035) 0·024% (0·019–0·031) 0·88 (0·63–1·23)
Pulmonary embolism32 0·006% (0·005–0·007) 0·078% (0·072–0·085) 12·99 (10·35–16·31)
Stroke (<75 years)33 0·034% (0·030–0·039) 0·025% (0·021–0·029) 0·72 (0·59–0·88)
Septic arthritis (native 
knee joint infection)34
0·001% (0·001–0·002)† 0·135% (0·126–0·144) 110·21 (81·19–149·60)
*Mortality data are Office for National Statistics population-level data for England, 2016, excluding death from cancer. 
†Excludes iatrogenic causes.
Table 4: 90-day adverse event rates in the general population vs a matched sample of the study cohort
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We analysed observational HES data, as recorded by 
hospitals in England for the purposes of reimbursement 
for treatment, clinical audit, and research. A wealth of 
data is recorded, but data quality varies between recorded 
fields. As hospitals rely on the coding of surgical 
procedures and serious acute medical diagnoses for 
financial reimbursement, there is a strong incentive to 
correctly and reliably enter these data, which we used in 
our study. In support of this reasoning, the modified 
Charlson comorbidity index as calculated from HES 
diagnosis fields and records of serious vascular com­
plications correlate strongly with primary care records.47,48 
Other fields are less reliably coded. Ethnicity data, for 
example, was missing for 13·64% of cases in our cohort. 
To minimise the effect of missing data, look­back and 
look­forward analyses of other hospital episodes for the 
same patient were done when app ro priate but, without 
direct validation, missing or in accurately coded data 
remains a possibility. Although a limitation of the HES 
database is that private hospital treatment is not recorded, 
we believe that the effect of this omission on our findings 
will have been minimal. Patients under going a primary 
procedure in the NHS are highly likely to have returned 
to an NHS hospital after development of an adverse 
event. Because the HES records hospital attend ances 
across England, compli cations within 90 days are 
unlikely to have been missed because of migration.
Our study included death certificate data from the 
ONS, which maintains a complete national record of both 
in­hospital and community deaths. Our analysis was, 
however, restricted to hospital episodes, and complications 
managed in the community were not available. For 
example, because a large proportion of patients with 
symptomatic deep vein thromboses are now diagnosed 
and treated in the community, this complication was not 
included as an outcome in our study. Any analysis of the 
frequency of deep vein thrombosis based on hospital 
episodes only would probably underestimate the true 
rate. The purpose of our study was to establish the 
rate of serious complications diagnosed in hospital. We 
comprehensively report the full range of the serious 
complications that might occur, rather than focusing on 
a few specific complications, as has been done in 
previous studies.
Clinical trial evidence, published mainly in the past 
6 years, has challenged the efficacy of arthroscopic partial 
meniscectomy, and the procedure is now advocated only in 
patients with specific radiological findings that correspond 
with symptoms, and only after a trial of conservative 
treatment. Overall, our study suggests that arthroscopic 
partial meniscectomy is a low­risk procedure, with no 
detected attributable risk of myocardial infarction, stroke, 
or death. Our findings support potential use of arthroscopic 
partial meniscectomy in carefully selected patients. When 
the anticipated benefit is low, however, overuse of the 
procedure is a concern and the potential morbidity from 
rare but serious complications should be considered. 
Specifically, we estimated that one pul monary embolism 
could be avoided for every 1390 fewer arthroscopic partial 
meniscectomies done, and one native knee joint infection 
could be avoided for every 749 fewer procedures done. 
The risks of pulmonary embolism and infection have 
not changed over time despite modern approaches to 
prevention. In view of the current scrutiny of shared 
decision making and individualised consent, our findings 
will help clinicians and patients to balance anticipated 
benefits and risks. The focus on implementation of 
enhanced treatment guidelines is justified to reduce 
avoidable risk and morbidity.
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